glp-1 kidney function receptor agonists and next-generation metabolic hormone therapies in chronic disease Effects of Semaglutide on CKD

Comments: This indication is approved under accelerated approval based on improvement of metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis

Completely safe

doi:10.1016/j.ajem.2024.01.010 WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults

But as their popularity grows, so does the research into long-term side effects of GLP-1 medications

Strategic Diet Breaks A one to two week period at maintenance calories can paradoxically restart weight loss afterward

HF is directly related to the thickening and stiffening of the arteries as the results of, for example, atherosclerosis